rs1800455
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000133.4(F9):āc.819T>Cā(p.Val273Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00161 in 1,198,637 control chromosomes in the GnomAD database, including 2 homozygotes. There are 599 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0011 ( 0 hom., 34 hem., cov: 23)
Exomes š: 0.0017 ( 2 hom. 565 hem. )
Consequence
F9
NM_000133.4 synonymous
NM_000133.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.209
Genes affected
F9 (HGNC:3551): (coagulation factor IX) This gene encodes vitamin K-dependent coagulation factor IX that circulates in the blood as an inactive zymogen. This factor is converted to an active form by factor XIa, which excises the activation peptide and thus generates a heavy chain and a light chain held together by one or more disulfide bonds. The role of this activated factor IX in the blood coagulation cascade is to activate factor X to its active form through interactions with Ca+2 ions, membrane phospholipids, and factor VIII. Alterations of this gene, including point mutations, insertions and deletions, cause factor IX deficiency, which is a recessive X-linked disorder, also called hemophilia B or Christmas disease. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing. [provided by RefSeq, Sep 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.7).
BP6
Variant X-139560836-T-C is Benign according to our data. Variant chrX-139560836-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 10600.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.209 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00113 (126/111966) while in subpopulation NFE AF= 0.00178 (95/53222). AF 95% confidence interval is 0.00149. There are 0 homozygotes in gnomad4. There are 34 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 34 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
F9 | NM_000133.4 | c.819T>C | p.Val273Val | synonymous_variant | 7/8 | ENST00000218099.7 | NP_000124.1 | |
F9 | NM_001313913.2 | c.705T>C | p.Val235Val | synonymous_variant | 6/7 | NP_001300842.1 | ||
F9 | XM_005262397.5 | c.690T>C | p.Val230Val | synonymous_variant | 6/7 | XP_005262454.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
F9 | ENST00000218099.7 | c.819T>C | p.Val273Val | synonymous_variant | 7/8 | 1 | NM_000133.4 | ENSP00000218099.2 | ||
F9 | ENST00000394090.2 | c.705T>C | p.Val235Val | synonymous_variant | 6/7 | 1 | ENSP00000377650.2 | |||
F9 | ENST00000643157.1 | n.1486T>C | non_coding_transcript_exon_variant | 5/7 |
Frequencies
GnomAD3 genomes AF: 0.00113 AC: 126AN: 111914Hom.: 0 Cov.: 23 AF XY: 0.000998 AC XY: 34AN XY: 34082
GnomAD3 genomes
AF:
AC:
126
AN:
111914
Hom.:
Cov.:
23
AF XY:
AC XY:
34
AN XY:
34082
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00137 AC: 251AN: 183416Hom.: 0 AF XY: 0.00149 AC XY: 101AN XY: 67866
GnomAD3 exomes
AF:
AC:
251
AN:
183416
Hom.:
AF XY:
AC XY:
101
AN XY:
67866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00166 AC: 1799AN: 1086671Hom.: 2 Cov.: 28 AF XY: 0.00160 AC XY: 565AN XY: 352505
GnomAD4 exome
AF:
AC:
1799
AN:
1086671
Hom.:
Cov.:
28
AF XY:
AC XY:
565
AN XY:
352505
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00113 AC: 126AN: 111966Hom.: 0 Cov.: 23 AF XY: 0.000996 AC XY: 34AN XY: 34144
GnomAD4 genome
AF:
AC:
126
AN:
111966
Hom.:
Cov.:
23
AF XY:
AC XY:
34
AN XY:
34144
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
F9-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 21, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Hereditary factor IX deficiency disease;C2749016:Thrombophilia, X-linked, due to factor 9 defect Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Hereditary factor IX deficiency disease Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
FACTOR IX, DNA POLYMORPHISM Benign:1
Benign, no assertion criteria provided | literature only | OMIM | Sep 01, 1989 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at